IDH2 and acute myeloid leukemia: In addition, in patients with IDH mutated AML at diagnosis, the same mutation persisted in over 95% of IDH1-mutated and IDH2-mutated AML cases at relapse (Chou et al., 2010, 2011b; Schnittger et al., 2010; Thol et al., 2010a).